Results 151 to 160 of about 1,535,618 (326)

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy

open access: yesFrontiers in Neuroscience
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years.
Grace A. Borchert   +14 more
doaj   +1 more source

Two potentially distinct pathways to geographic atrophy in age-related macular degeneration characterized by quantitative fundus autofluorescence

open access: yesEye, 2023
Wei Wei   +7 more
semanticscholar   +1 more source

Potential contribution of biomass gasification‐based technology in energy transition: a technical review coupled with bibliometric studies

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biomass gasification technology has been extensively researched around the world; however, there is a need to evaluate the current research landscape and evolutionary direction of research in the broader context of energy transition. A systematic bibliometric analysis of the Web of Science database was performed for articles that fall within ...
Olasunkanmi Opeoluwa Adeoye   +5 more
wiley   +1 more source

Techno‐economic and environmental assessment of a hybrid renewable energy system for a date molasses factory in Iraq using HOMER Pro

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Iraq currently faces a significant electricity deficit estimated at approximately 18 000 MW, resulting in frequent and sometimes prolonged power outages that disrupt both economic activities and social life. The widening gap between energy supply and demand, combined with environmental concerns associated with fossil fuel consumption ...
Safaa Malik Abbas   +3 more
wiley   +1 more source

Multimodal imaging for evaluation and quantification of atrophy progression in extensive macular atrophy with pseudodrusen

open access: yesPhotodiagnosis and Photodynamic Therapy
Aim: To present the atrophy progression rate with fundus autofluorescence (FAF) and optical coherence tomography (OCT) findings in patients with extensive macular atrophy with a pseudodrusen-like appearance.
Rukiye Aydin, Merve Ozbek, Ozgur Artunay
doaj   +1 more source

Market potential of biobased chemicals: a qualitative network analysis of adoption dynamics in South Africa’s bioeconomy

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract The premise of a bioeconomy is the replacement of nonrenewable and unsustainable fossil‐derived resources and associated technologies with more sustainable alternatives. The adoption of biobased chemicals contributes toward the growth of a bioeconomy and is dependent on market and industry requirements.
Prisha Mandree   +2 more
wiley   +1 more source

Potential role of lampalizumab for treatment of geographic atrophy [Retraction]

open access: yesClinical Ophthalmology, 2015
Rhoades W, Dickson D, Do DV. Clinical Ophthalmology. 2015;9:1049–1056.The authors respectfully retract this review article. We realize that some of the results referenced in this manuscript are preliminary analyses and may not reflect the final ...
Rhoades W, Dickson D, Do DV
doaj  

Potential Use of Plasma Rich in Growth Factors in Age-Related Macular Degeneration: Evidence from a Mouse Model

open access: yesMedicina
Background and Objectives: Age-related macular degeneration (AMD) is the leading cause of low vision and legal blindness in adults in developed countries.
Eduardo Anitua   +4 more
doaj   +1 more source

Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular Degeneration [PDF]

open access: bronze, 2019
Felix Graßmann   +16 more
openalex   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy